A total of @ patients with acute ischemic stroke were identified for eligibility in a randomized , double-blind , placebo-controlled clinical trial , of which @ patients allocated to either receiving NeuroAiD ( @ cases ) or placebo ( @ cases ) were analyzed after dropouts due to absence of baseline data , early death , or noncompliance .